On February 24, 2022, Davis Polk partner Steve Wang will be among the speakers at Bloomberg Intelligence’s “China’s biotech & biopharma capital market reset” webinar. Topics discussed will include whether to expect a shift to new sub-sectors such as new therapeutic platforms, AI and tech-based services, whether valuations have bottomed-out or if there will be a near-term rebound and the risks of official policy changes.

For more information, please visit the event website.

Copy link to share post